Federico Innocenti
University of North Carolina at Chapel Hill
H-index: 62
North America-United States
Top articles of Federico Innocenti
Germline cis variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD)
bioRxiv
2023/11/4
Ting Zhang
H-Index: 15
Federico Innocenti
H-Index: 33
Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies
2024/3/11
Akram Yazdani
H-Index: 8
Gianluigi Pillonetto
H-Index: 26
Heinz-Josef Lenz
H-Index: 72
Andrew Nixon
H-Index: 2
Federico Innocenti
H-Index: 33
CCALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C infection in Patients with advanced hepatocellular carcinoma
Cancer Research Communications
2024/2/16
Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer
European Journal of Cancer
2024/2/10
Hiroyuki Arai
H-Index: 15
Yan Yang
H-Index: 13
Joshua Millstein
H-Index: 16
Federico Innocenti
H-Index: 33
Jingyuan Wang
H-Index: 16
Francesca Battaglin
H-Index: 17
Priya Jayachandran
H-Index: 10
Wu Zhang
H-Index: 31
Emil Lou
H-Index: 24
Benjamin A Weinberg
H-Index: 11
John Marshall
H-Index: 3
Sanjay Goel
H-Index: 15
Heinz-Josef Lenz
H-Index: 72
DNA mutational profiling in patients with colorectal cancer treated with standard of care reveals differences in outcome and racial distribution of mutations
Journal of Clinical Oncology
2024/2/1
Genome-wide association study (GWAS) and novel prognostic markers in metastatic colorectal cancer (mCRC).
2024/1/20
Myostatin/activin pathway gene expression and single nucleotide polymorphisms (SNPs) in metastatic colorectal cancer (mCRC).
2024/1/20
CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value
Journal for Immunotherapy of Cancer
2024
Francesca Battaglin
H-Index: 17
Joshua Millstein
H-Index: 16
Yan Yang
H-Index: 13
Hiroyuki Arai
H-Index: 15
Jingyuan Wang
H-Index: 16
Federico Innocenti
H-Index: 33
Priya Jayachandran
H-Index: 10
Annika Lenz
H-Index: 3
Wu Zhang
H-Index: 31
Evanthia Roussos Torres
H-Index: 13
Emil Lou
H-Index: 24
Benjamin A Weinberg
H-Index: 11
Heinz-Josef Lenz
H-Index: 72
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapy
2023/12/15
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance)
medRxiv
2023/12/4
Layne Rogers
H-Index: 1
William Kelly
H-Index: 11
Andrew B Nixon
H-Index: 22
Federico Innocenti
H-Index: 33
Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients
The Pharmacogenomics Journal
2023/7
Sushant A Patil
H-Index: 6
Federico Innocenti
H-Index: 33
Identification of reduced ERAP2 expression and a novel HLA allele as components of a risk score for susceptibility to liver injury due to amoxicillin-clavulanate
Gastroenterology
2023/3/1
Andrew Dellinger
H-Index: 9
Naga Chalasani
H-Index: 70
Andrew Stolz
H-Index: 23
Federico Innocenti
H-Index: 33
Olivier Govaere
H-Index: 29
Acquired genomic alterations on first-line chemotherapy with cetuximab in advanced colorectal cancer: circulating tumor DNA analysis of the CALGB/SWOG-80405 trial (Alliance)
Journal of Clinical Oncology
2023/1/20
Federico Innocenti
H-Index: 33
Heinz-Josef Lenz
H-Index: 72
Predictive value of MAOB gene expression for targeted therapy in patients (pts) with metastatic colorectal cancer (mCRC) enrolled in CALGB (Alliance)/SWOG 80405.
2022/6/1
Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis
Journal of geriatric oncology
2022/5/1
Tumor immunogenomic features determine outcomes in patients with metastatic colorectal Cancer treated with standard-of-care combinations of Bevacizumab and Cetuximab
Clinical Cancer Research
2022/4/14
Federico Innocenti
H-Index: 33
Akram Yazdani
H-Index: 8
Naim Rashid
H-Index: 20
Scott Van Buren
H-Index: 6
Heinz-Josef Lenz
H-Index: 72
Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021; 44: 2673–2682
Diabetes Care
2021/12/1
Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021; 44: 2673–2682
Diabetes Care
2022/4
Adem Y Dawed
H-Index: 8
Sook Wah Yee
H-Index: 31
Yanfei Zhang
H-Index: 11
Moneeza K Siddiqui
H-Index: 6
Federico Innocenti
H-Index: 33
Fei Xu
H-Index: 11
Yu-Chuan Chang
H-Index: 6
John S Witte
H-Index: 44
Roderick Slieker
H-Index: 22
Fariba Ahmadizar
H-Index: 12
Ivan Tkac
H-Index: 28
Sook Wah Yee
H-Index: 31
Michael Wagner
H-Index: 18
Kim Brøsen
H-Index: 30
All You Need to Know About UGT1A1 Genetic Testing for Patients Treated With Irinotecan: A Practitioner-Friendly Guide
JCO Oncology Practice
2022/4
Federico Innocenti
H-Index: 33
Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients
British Journal of Cancer
2022/3/9
Federico Innocenti
H-Index: 33
